Close Menu

You may find more results for this query on our sister sites: GenomeWeb and 360Dx.

Home › Diagnostics › Biomarker Discovery & Validation

Biomarker Discovery & Validation

News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.

Ariz Precision Medicine Bets on a New Class of Cancer Drugs Targeting PRDM Genes

Premium

The startup biotech has spent four years researching PRDM genes in various cancers and is coming out of stealth mode with a lead candidate in lung cancer.

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients.

Jubilant Therapeutics, OneThree Biotech ID Biomarkers for LSD1, HDAC6 Inhibitor

Using OneThree's AI platform, Jubilant has identified biomarker-defined cancer indications that it hopes to pursue for JBI-802 in human trials next year.

Pfizer Turns to Health Social Network to Find Patients With Rare Lung Cancer Genetic Variants

Premium

The drugmaker has partnered with Inspire and others to find study participants who have a genetic resilience to lung cancer.

Multi-Biomarker Strategies Show Promise in Improving Immunotherapy Response Prediction

Premium

In two studies at ESMO, researchers demonstrated the ability of combined biomarker approaches to predict the efficacy of immune checkpoint inhibitors.

Sep 15, 2020

Cofactor Genomics, UCSD Partner on Metastatic Head, Neck Cancer Study

Sep 10, 2020

Epic Sciences, MSK Identify Potential Prostate Cancer Therapy Response Biomarker

Premium
Aug 26, 2020

Oncolytics Biotech Doses First TNBC Patient in Phase II Trial of Peloreorep, Retifanlimab Combo

Aug 12, 2020

GeneCentric Therapeutics, Janssen Partner to Uncover Bladder Cancer Biomarkers

Aug 11, 2020

Caris Life Sciences, Elevation Oncology Partner on Patient Enrollment for Tumor-Agnostic Drug Trial

Aug 06, 2020

GeneCentric, Erasmus University to Research RNA Biomarkers, Therapies for Bladder Cancer

Aug 04, 2020

T-Cure Bioscience, NHLBI Collaborate to Advance Targeted T-Cell Receptor Therapy

Jul 31, 2020

Merus, Elevation Oncology Advance Drug Candidates Targeting NRG1 Fusion-Positive Cancers

Premium
Jul 29, 2020

Repare Therapeutics Doses First Patient in Phase I/II Trial of ATR Inhibitor RP-3500

Jul 29, 2020

Pancreatic Cancer Action Network, GeneCentric Therapeutics Launch Research Partnership

Jul 22, 2020

Ultivue, OracleBio Collaborate on Tissue Biomarker Analysis Workflow

Jul 22, 2020

Daiichi Sankyo, Gustave Roussy to Study Antibody Drug Conjugates, Identify Predictive Biomarkers

Jul 08, 2020

Lantern Pharma Making Headway in Using AI to Revive Old Drugs, Develop New Compounds

Premium
Jul 01, 2020

Pfizer's Ibrance Shows 'Modest' Antitumor Activity in Patients With CDKN2A-Altered Lung Cancer

Jun 17, 2020

Bladder Cancer Patients With ARID1A Mutation, CXCL13 Expression Respond Better to Immunotherapy

Apr 30, 2020

TMB Harmonization Data Extends Concordance Findings, Tests Calibration Methods

Apr 08, 2020

Oncolytics Biotech Advances Virus-Based Cancer Treatment in Biomarker-Defined Populations

Premium
Apr 07, 2020

Blood-Based Genetic Risk Score Shows Promise for Prostate Cancer Drug Response, Survival Prediction

Premium
Apr 07, 2020

Merck's Keytruda sBLA for Tumor Mutation Burden-High Cancer Patients Accepted by FDA

Mar 30, 2020

Phase I Study of Novel Drug Shows Preliminary Activity in Mesothelin-Expressing Tumors

More articles
Mar
25
Featured Webinar

Virtual Molecular Tumor Board Series: What to Do with a ‘Negative’ Molecular Panel Case

Sponsored by
Foundation Medicine

In this session, the fourth in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling identified no clear molecular markers to help guide personalized therapy.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.